1. Home
  2. TWST vs RXRX Comparison

TWST vs RXRX Comparison

Compare TWST & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • RXRX
  • Stock Information
  • Founded
  • TWST 2013
  • RXRX 2013
  • Country
  • TWST United States
  • RXRX United States
  • Employees
  • TWST N/A
  • RXRX N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TWST Health Care
  • RXRX Health Care
  • Exchange
  • TWST Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • TWST 2.6B
  • RXRX 2.6B
  • IPO Year
  • TWST 2018
  • RXRX 2021
  • Fundamental
  • Price
  • TWST $38.21
  • RXRX $5.29
  • Analyst Decision
  • TWST Buy
  • RXRX Buy
  • Analyst Count
  • TWST 10
  • RXRX 4
  • Target Price
  • TWST $52.50
  • RXRX $8.25
  • AVG Volume (30 Days)
  • TWST 1.0M
  • RXRX 16.6M
  • Earning Date
  • TWST 05-01-2025
  • RXRX 05-08-2025
  • Dividend Yield
  • TWST N/A
  • RXRX N/A
  • EPS Growth
  • TWST N/A
  • RXRX N/A
  • EPS
  • TWST N/A
  • RXRX N/A
  • Revenue
  • TWST $330,189,000.00
  • RXRX $58,839,000.00
  • Revenue This Year
  • TWST $22.62
  • RXRX $72.81
  • Revenue Next Year
  • TWST $17.76
  • RXRX $51.04
  • P/E Ratio
  • TWST N/A
  • RXRX N/A
  • Revenue Growth
  • TWST 25.85
  • RXRX 32.00
  • 52 Week Low
  • TWST $27.41
  • RXRX $4.95
  • 52 Week High
  • TWST $60.90
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • TWST 39.46
  • RXRX 34.95
  • Support Level
  • TWST $37.12
  • RXRX $6.27
  • Resistance Level
  • TWST $40.80
  • RXRX $6.94
  • Average True Range (ATR)
  • TWST 2.48
  • RXRX 0.38
  • MACD
  • TWST -0.12
  • RXRX -0.09
  • Stochastic Oscillator
  • TWST 13.41
  • RXRX 17.09

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: